Skip to main content
Clinical Trials/CTRI/2021/06/033985
CTRI/2021/06/033985
Completed
未知

Effect of Non Surgical Periodontal therapy in patients with Periodontitis and Type 2 Diabetes Mellitus

Haldia Institute of dental sciences and research0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Haldia Institute of dental sciences and research
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Haldia Institute of dental sciences and research

Eligibility Criteria

Inclusion Criteria

  • Subjects with Gingivitis : full mouth bleeding on probing less than 10% of sites.
  • Subjects with Periodontitis : Subjects with Periodontitis with interdental clinical attachment
  • loss detectable at \>\- 2 non adjacent teeth .Buccal or oral clinical attachment loss \>\-3 mm
  • with pocketing \> 3mm is detectable at \>\-2 teeth.
  • Subjects with Periodontally Healthy (PH) : Subjects with PH will have no history of periodontitis, no sites with PD and CAL \> 3 mm concurrently and no more than 10% of the sites with gingival bleeding and/or BoP.
  • Diabetic subjects :The diabetic subjects will require a diagnosis of DM confirmed by a physician, dating from at least 2 years prior to the study. In addition, all diabetic patients will be required to have a HbA1c \> 6\.5% and FPG \> 99 mg/dl.
  • Non\-diabetics: Non\-diabetic subjects will have no history of DM, HbA1c \= 6\.0% and FPG \< 99 mg/dl.

Exclusion Criteria

  • Pregnancy; breastfeeding; subgingival periodontal therapy during the previous 12 months; use of antibiotic, anti\-inflammatory, and/or immunosuppressive therapies during the previous 6 months; regular use of mouthrinses containing antimicrobials; use of orthodontic
  • appliances; presence of other infectious, immunological, and/or inflammatory systemic conditions (e.g., immunological disorders, rheumatoid arthritis) and major complications of DM (i.e.,ulcers, gangrene, amputation, neuropathy, and nephropathy),smokers.

Outcomes

Primary Outcomes

Not specified

Similar Trials